Mengya Zhong

机构：Xiamen University, First Affiliated Hospital of Xiamen University, Zhongshan Hospital of Xiamen University

发表论文 54 篇 · 总被引 967 次 · h-index 17

代表论文

• Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia (2022 · Cancer Letters · 被引 39)
• MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota (2023 · Frontiers in Immunology · 被引 15)
• Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy (2025 · Nature Communications · 被引 11)
• Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway (2023 · Discover Oncology · 被引 11)
• Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway (2022 · Pharmaceuticals · 被引 10)
• Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling (2022 · Journal of Cancer Research and Clinical Oncology · 被引 8)